Literature DB >> 22870456

Is there a place for nonbiological drugs in the treatment of rheumatoid arthritis?

Alejandro Balsa1, Miriam García-Arias.   

Abstract

Entities:  

Year:  2010        PMID: 22870456      PMCID: PMC3383494          DOI: 10.1177/1759720X10384434

Source DB:  PubMed          Journal:  Ther Adv Musculoskelet Dis        ISSN: 1759-720X            Impact factor:   5.346


× No keyword cloud information.
  50 in total

1.  Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.

Authors:  P E Lipsky; D M van der Heijde; E W St Clair; D E Furst; F C Breedveld; J R Kalden; J S Smolen; M Weisman; P Emery; M Feldmann; G R Harriman; R N Maini
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

2.  Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis.

Authors:  M Boers; A C Verhoeven; H M Markusse; M A van de Laar; R Westhovens; J C van Denderen; D van Zeben; B A Dijkmans; A J Peeters; P Jacobs; H R van den Brink; H J Schouten; D M van der Heijde; A Boonen; S van der Linden
Journal:  Lancet       Date:  1997-08-02       Impact factor: 79.321

3.  Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial.

Authors:  Y P M Goekoop-Ruiterman; J K de Vries-Bouwstra; C F Allaart; D van Zeben; P J S M Kerstens; J M W Hazes; A H Zwinderman; H K Ronday; K H Han; M L Westedt; A H Gerards; J H L M van Groenendael; W F Lems; M V van Krugten; F C Breedveld; B A C Dijkmans
Journal:  Arthritis Rheum       Date:  2005-11

4.  Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis.

Authors:  Timo Möttönen; Pekka Hannonen; Markku Korpela; Martti Nissilä; Hannu Kautiainen; Jorma Ilonen; Leena Laasonen; Oili Kaipiainen-Seppänen; Per Franzen; Tapani Helve; Juhani Koski; Marianne Gripenberg-Gahmberg; Riitta Myllykangas-Luosujärvi; Marjatta Leirisalo-Repo
Journal:  Arthritis Rheum       Date:  2002-04

5.  Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial.

Authors:  E William St Clair; Désirée M F M van der Heijde; Josef S Smolen; Ravinder N Maini; Joan M Bathon; Paul Emery; Edward Keystone; Michael Schiff; Joachim R Kalden; Ben Wang; Kimberly Dewoody; Roberta Weiss; Daniel Baker
Journal:  Arthritis Rheum       Date:  2004-11

6.  Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events.

Authors:  K G Saag; R Koehnke; J R Caldwell; R Brasington; L F Burmeister; B Zimmerman; J A Kohler; D E Furst
Journal:  Am J Med       Date:  1994-02       Impact factor: 4.965

7.  Heterogeneity of rheumatoid arthritis: from phenotypes to genotypes.

Authors:  C M Weyand; P A Klimiuk; J J Goronzy
Journal:  Springer Semin Immunopathol       Date:  1998

8.  Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission.

Authors:  Esmeralda T H Molenaar; Alexandre E Voskuyl; Huib J Dinant; P Dick Bezemer; Maarten Boers; Ben A C Dijkmans
Journal:  Arthritis Rheum       Date:  2004-01

9.  Impact of shared epitope genotype and ethnicity on erosive disease: a meta-analysis of 3,240 rheumatoid arthritis patients.

Authors:  Jennifer D Gorman; Raymond F Lum; John J Chen; Maria E Suarez-Almazor; Glenys Thomson; Lindsey A Criswell
Journal:  Arthritis Rheum       Date:  2004-02

10.  Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: II. Second line drugs and prednisone.

Authors:  T Pincus; S B Marcum; L F Callahan
Journal:  J Rheumatol       Date:  1992-12       Impact factor: 4.666

View more
  2 in total

Review 1.  Tofacitinib: a review of its use in adult patients with rheumatoid arthritis.

Authors:  Lesley J Scott
Journal:  Drugs       Date:  2013-06       Impact factor: 9.546

Review 2.  Certolizumab pegol: a review of its use in the management of rheumatoid arthritis.

Authors:  Emma D Deeks
Journal:  Drugs       Date:  2013-01       Impact factor: 11.431

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.